Table 1.
CTR n = 50 |
RA n = 56 |
p | |
---|---|---|---|
Age (years) | 56.5 (49.8–65.3) | 62.5 (54.5–6.0) | 0.116 |
Female | 46 (92.0) | 52 (92.9) | 1.000 |
BMI (Kg/m2) | 28.2 (25.9–31.3) | 28.6 (25.4–31.7) | 0.651 |
WC (cm) | 96.0 (91.0–102.5) | 96.0 (89.3–106.0) | 0.761 |
Obesity | 16 (32.0) | 21 (37.5) | 0.684 |
Dyslipidemia | 22 (44.0) | 18 (32.1) | 0.233 |
Statin use | 10 (20.0) | 10 (17.9) | 0.808 |
Post-menopausal | 34 (73.9) | 45 (86.5) | 0.132 |
HRT | 5 (10.9) | 10 (19.2) | 0.277 |
HC | 3 (6.5) | 0 (0.0) | 0.100 |
Physical activity ≥ 150 min/wk | 10 (20.0) | 10 (17.9) | 0.808 |
DAS28 | 4.15 (3.28–5.03) | ||
Disease remission | 7 (12.5) | ||
Low-activity disease | 6 (10.7) | ||
Moderate-activity disease | 31 (55.4) | ||
High-activity disease | 12 (21.4) |
RA: rheumatoid arthritis group; CTR: control group; BMI: body mass index; DAS28: Disease Activity Score with 28-joint counts; WC: waist circumference; HRT: hormonal replacement therapy; HC: hormonal contraceptive. Results are expressed as median and interquartile intervals (25% and 75%) or n (%). Data were compared using the Mann–Whitney test and Fisher’s exact test for categorical variables, always as two-sided analyses.